GPs key for equitable access to glucose monitors: RACGP An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.
‘A major public health crisis’: Diabetes policy under scrutiny Could a new Parliamentary Inquiry help address gaps in knowledge about the disease, as well as improve policy?
Lower birthweight an independent risk factor for T2D: Study It is also linked to diagnosis at a younger age, a lower prevalence of overweight/obesity, and fewer family members with a history of diabetes.
RACGP opposes GLP-1 RA prescribing restrictions Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.
GLP-1 RA prescribing checks flagged GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.
Intermittent semaglutide availability until at least June Supply issues will remain while the medicine’s sponsor ‘continues to build stable stock supplies over coming weeks and months’.
In Practice: Managing tick-borne illnesses The information is aimed to further support health professionals and patients to better understand tick-borne illness in Australia.
Extended PBS access to ‘important’ insulin drug The Government is urging patients with type 1 diabetes to obtain a GP prescription by 1 April to ensure ongoing access to Fiasp.
Could screening vitamin C levels improve diabetes outcomes? According to new research, it may reduce the risk of disease-related complications. But a GP expert points to a more person-centred approach.
TGA warns of online semaglutide scams The medicines regulator has said scams include advertising offers being sent to GPs for distribution to patients.